Dr. Martens plc

LSE:DOCS Voorraadrapport

Marktkapitalisatie: UK£544.1m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Dr. Martens Beheer

Beheer criteriumcontroles 4/4

De CEO Dr. Martens' is Kenny Wilson, benoemd in Jul2018, heeft een ambtstermijn van 6.25 jaar. De totale jaarlijkse vergoeding van { bedraagt £ 788.00K, bestaande uit 93.3% salaris en 6.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.2% van de aandelen van het bedrijf, ter waarde £ 6.41M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.9 jaar en 3.8 jaar.

Belangrijke informatie

Kenny Wilson

Algemeen directeur

UK£788.0k

Totale compensatie

Percentage CEO-salaris93.3%
Dienstverband CEO6.3yrs
Eigendom CEO1.2%
Management gemiddelde ambtstermijn2.9yrs
Gemiddelde ambtstermijn bestuur3.8yrs

Recente managementupdates

Recent updates

Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet

Sep 21
Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet

Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?

Aug 20
Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?

Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger

Jul 20
Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger

There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings

Jun 19
There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings

Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%

May 21
Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%

The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Mar 27
The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet

Mar 06
Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet

Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price

Feb 08
Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price

Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market

Jan 21
Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market

Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156

Jan 03
Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156

Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156

Dec 13
Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156

Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation

Oct 12
Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation

Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Sep 13
Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)

Jul 12
Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)

A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Jun 02
A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)

Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency

Feb 25
Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency

Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?

Dec 17
Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?

The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Oct 02
The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested

Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively

Jul 04
Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively

Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge

Jun 16
Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge

Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?

Mar 02
Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?

Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price

Dec 01
Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price

Analyse CEO-vergoeding

Hoe is Kenny Wilson's beloning veranderd ten opzichte van Dr. Martens's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2024UK£788kUK£735k

UK£69m

Dec 31 2023n/an/a

UK£86m

Sep 30 2023n/an/a

UK£103m

Jun 30 2023n/an/a

UK£116m

Mar 31 2023UK£773kUK£721k

UK£129m

Dec 31 2022n/an/a

UK£153m

Sep 30 2022n/an/a

UK£177m

Jun 30 2022n/an/a

UK£179m

Mar 31 2022UK£2mUK£700k

UK£181m

Dec 31 2021n/an/a

UK£118m

Sep 30 2021n/an/a

UK£54m

Jun 30 2021n/an/a

UK£44m

Mar 31 2021UK£815kUK£118k

UK£35m

Compensatie versus markt: De totale vergoeding ($USD 1.05M ) Kenny } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 1.42M ).

Compensatie versus inkomsten: De vergoeding van Kenny is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Kenny Wilson (58 yo)

6.3yrs

Tenure

UK£788,000

Compensatie

Mr. Kenneth Wilson, also known as Kenny, is Chief Executive Officer at Dr. Martens Limited and Dr. Martens plc since July 2018 and serves as its Director since January 5, 2021. He joined Dr. Martens Limite...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Kenneth Wilson
CEO & Director6.3yrsUK£788.00k1.2%
£ 6.5m
Onyeije Nwokorie
Chief Brand Officerless than a yearUK£57.00k0%
£ 0
Giles Wilson
CFO & Directorless than a yeargeen gegevens0.017%
£ 90.8k
Geert Peeters
Chief Operating Officer6.3yrsgeen gegevensgeen gegevens
Graham Calder
Chief Technology Officerno datageen gegevensgeen gegevens
Bridget Jolliffe
Chief People Officerno datageen gegevensgeen gegevens
Emily Reichwald
Chief Sustainability Officerno datageen gegevensgeen gegevens
Sean O'Neill
Chief Digital Officer6.5yrsgeen gegevensgeen gegevens
Derek Chan
President of APAC5.1yrsgeen gegevensgeen gegevens
Adam Meek
Chief Product Officer2.8yrsgeen gegevensgeen gegevens
Jennifer Somer
President of Americas2.9yrsgeen gegevensgeen gegevens
Mike Stopforth
President of EMEA1.4yrsgeen gegevensgeen gegevens

2.9yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van DOCS wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.9 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Kenneth Wilson
CEO & Director3.8yrsUK£788.00k1.2%
£ 6.5m
Giles Wilson
CFO & Directorless than a yeargeen gegevens0.017%
£ 90.8k
Andrew Harrison
Independent Non-Executive Director1.4yrsUK£62.00k0.0080%
£ 43.3k
Ian Rogers
Independent Non-Executive Director3.8yrsUK£68.00k0.0021%
£ 11.5k
Robyn Perriss
Independent Non-Executive Director3.8yrsUK£96.00k0.010%
£ 56.2k
Tara Alhadeff
Representative Non-Independent Non-Executive Director3.8yrsgeen gegevensgeen gegevens
Lynne Weedall
Senior Independent Non-Executive Director3.8yrsUK£101.00k0.0048%
£ 26.1k
Paul Mason
Chair of the Board9.1yrsUK£342.00k0.82%
£ 4.5m

3.8yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van DOCS wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).